As for the KDM4A-CNP0371131 complex (which had the highest FRED/Chemgauss4 score) we observed that CNP0371131 was exclusive for KDM4A; thus, could be used as a treatment for cancers where only KDM4A is deregulated, such as Uterine Corpus Endometrioid Carcinoma and Testicular Germ Cell Tumor. This evidence concerns the gene KDM4A and endometrial endometrioid adenocarcinoma.